| Year |
Citation |
Score |
| 2022 |
Chesko DM, Wilgus TA. Immune Cells in Cutaneous Wound Healing: A Review of Functional Data from Animal Models. International Journal of Molecular Sciences. 23. PMID 35269586 DOI: 10.3390/ijms23052444 |
0.345 |
|
| 2021 |
Neves LMG, Wilgus T, Bayat A. , and Approaches for Investigation of Skin Scarring: Human and Animal Models. Advances in Wound Care. PMID 34915768 DOI: 10.1089/wound.2021.0139 |
0.353 |
|
| 2021 |
Ud-Din S, Wilgus TA, McGeorge DD, Bayat A. Pre-Emptive Priming of Human Skin Improves Cutaneous Scarring and Is Superior to Immediate and Delayed Topical Anti-Scarring Treatment Post-Wounding: A Double-Blind Randomised Placebo-Controlled Clinical Trial. Pharmaceutics. 13. PMID 33917842 DOI: 10.3390/pharmaceutics13040510 |
0.334 |
|
| 2021 |
DiPietro LA, Wilgus TA, Koh TJ. Macrophages in Healing Wounds: Paradoxes and Paradigms. International Journal of Molecular Sciences. 22. PMID 33477945 DOI: 10.3390/ijms22020950 |
0.434 |
|
| 2021 |
Wilgus TA. A Murine Incisional Fetal Wound-Healing Model to Study Scarless and Fibrotic Skin Repair. Methods in Molecular Biology (Clifton, N.J.). 2193: 13-21. PMID 32808254 DOI: 10.1007/978-1-0716-0845-6_2 |
0.56 |
|
| 2020 |
Wilgus TA, Ud-Din S, Bayat A. A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis. International Journal of Molecular Sciences. 21. PMID 33353063 DOI: 10.3390/ijms21249673 |
0.411 |
|
| 2020 |
Gnyawali SC, Sinha M, El Masry MS, Wulff B, Ghatak S, Soto-Gonzalez F, Wilgus TA, Roy S, Sen CK. High resolution ultrasound imaging for repeated measure of wound tissue morphometry, biomechanics and hemodynamics under fetal, adult and diabetic conditions. Plos One. 15: e0241831. PMID 33227015 DOI: 10.1371/journal.pone.0241831 |
0.333 |
|
| 2020 |
Wilgus TA. Inflammation as an orchestrator of cutaneous scar formation: a review of the literature. Plastic and Aesthetic Research. 7. PMID 33123623 DOI: 10.20517/2347-9264.2020.150 |
0.442 |
|
| 2020 |
Ud-Din S, Wilgus TA, Bayat A. Mast Cells in Skin Scarring: A Review of Animal and Human Research. Frontiers in Immunology. 11: 552205. PMID 33117341 DOI: 10.3389/fimmu.2020.552205 |
0.458 |
|
| 2020 |
Blackstone BN, Wilgus TA, Roy S, Wulff BC, Powell HM. Skin Biomechanics and miRNA Expression Following Chronic UVB Irradiation. Advances in Wound Care. 9: 79-89. PMID 31993250 DOI: 10.1089/Wound.2019.1034 |
0.453 |
|
| 2019 |
Wilgus TA. Vascular Endothelial Growth Factor and Cutaneous Scarring. Advances in Wound Care. 8: 671-678. PMID 31750015 DOI: 10.1089/Wound.2018.0796 |
0.465 |
|
| 2018 |
Wulff BC, Pappa NK, Wilgus TA. Interleukin-33 encourages scar formation in murine fetal skin wounds. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. PMID 30368969 DOI: 10.1111/Wrr.12687 |
0.494 |
|
| 2018 |
Wilgus TA. Alerting the body to tissue injury: The role of alarmins and DAMPs in cutaneous wound healing. Current Pathobiology Reports. 6: 55-60. PMID 29862143 DOI: 10.1007/S40139-018-0162-1 |
0.488 |
|
| 2017 |
Wilgus TA. New Mechanisms of ECM Production during Wound Healing: A Role for Parathyroid Hormone 2 Receptor Signaling. The Journal of Investigative Dermatology. 137: 1617-1619. PMID 28735615 DOI: 10.1016/J.Jid.2017.05.001 |
0.401 |
|
| 2014 |
Johnson KE, Wilgus TA. Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair. Advances in Wound Care. 3: 647-661. PMID 25302139 DOI: 10.1089/Wound.2013.0517 |
0.429 |
|
| 2014 |
Wilgus TA, Wulff BC. The Importance of Mast Cells in Dermal Scarring. Advances in Wound Care. 3: 356-365. PMID 24757590 DOI: 10.1089/Wound.2013.0457 |
0.425 |
|
| 2014 |
Chen L, Schrementi ME, Ranzer MJ, Wilgus TA, DiPietro LA. Blockade of mast cell activation reduces cutaneous scar formation. Plos One. 9: e85226. PMID 24465509 DOI: 10.1371/Journal.Pone.0085226 |
0.555 |
|
| 2013 |
Wilgus TA, Roy S, McDaniel JC. Neutrophils and Wound Repair: Positive Actions and Negative Reactions. Advances in Wound Care. 2: 379-388. PMID 24527354 DOI: 10.1089/Wound.2012.0383 |
0.487 |
|
| 2013 |
Wulff BC, Wilgus TA. Examining the role of mast cells in fetal wound healing using cultured cells in vitro. Methods in Molecular Biology (Clifton, N.J.). 1037: 495-506. PMID 24029955 DOI: 10.1007/978-1-62703-505-7_29 |
0.541 |
|
| 2013 |
Johnson KE, Wulff BC, Oberyszyn TM, Wilgus TA. Ultraviolet light exposure stimulates HMGB1 release by keratinocytes. Archives of Dermatological Research. 305: 805-15. PMID 23942756 DOI: 10.1007/S00403-013-1401-2 |
0.745 |
|
| 2013 |
Wulff BC, Wilgus TA. Mast cell activity in the healing wound: more than meets the eye? Experimental Dermatology. 22: 507-10. PMID 23802591 DOI: 10.1111/Exd.12169 |
0.551 |
|
| 2013 |
McDaniel JC, Roy S, Wilgus TA. Neutrophil activity in chronic venous leg ulcers--a target for therapy? Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 21: 339-51. PMID 23551462 DOI: 10.1111/Wrr.12036 |
0.409 |
|
| 2013 |
Dardenne AD, Wulff BC, Wilgus TA. The alarmin HMGB-1 influences healing outcomes in fetal skin wounds. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 21: 282-91. PMID 23438257 DOI: 10.1111/Wrr.12028 |
0.566 |
|
| 2013 |
Wulff BC, Yu L, Parent AE, Wilgus TA. Novel differences in the expression of inflammation-associated genes between mid- and late-gestational dermal fibroblasts. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 21: 103-12. PMID 23126606 DOI: 10.1111/J.1524-475X.2012.00860.X |
0.467 |
|
| 2012 |
Wilgus TA. Growth Factor-Extracellular Matrix Interactions Regulate Wound Repair. Advances in Wound Care. 1: 249-254. PMID 24527314 DOI: 10.1089/Wound.2011.0344 |
0.426 |
|
| 2012 |
Johnson KE, Wilgus TA. Multiple roles for VEGF in non-melanoma skin cancer: angiogenesis and beyond. Journal of Skin Cancer. 2012: 483439. PMID 23125933 DOI: 10.1155/2012/483439 |
0.533 |
|
| 2012 |
Wilgus TA, DiPietro LA. Complex roles for VEGF in dermal wound healing. The Journal of Investigative Dermatology. 132: 493-4. PMID 22071479 DOI: 10.1038/Jid.2011.343 |
0.443 |
|
| 2012 |
Wulff BC, Parent AE, Meleski MA, DiPietro LA, Schrementi ME, Wilgus TA. Mast cells contribute to scar formation during fetal wound healing. The Journal of Investigative Dermatology. 132: 458-65. PMID 21993557 DOI: 10.1038/Jid.2011.324 |
0.53 |
|
| 2012 |
Nye KE, Lachey MK, Parent AE, Wilgus TA. Abstract 2536: VEGF as a potential survival factor for keratinocytes following UV exposurein vivo Cancer Research. 72: 2536-2536. DOI: 10.1158/1538-7445.Am2012-2536 |
0.48 |
|
| 2008 |
Wilgus TA. Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacological Research. 58: 112-6. PMID 18723091 DOI: 10.1016/J.Phrs.2008.07.009 |
0.42 |
|
| 2008 |
Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA. Regulation of scar formation by vascular endothelial growth factor. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 579-90. PMID 18427552 DOI: 10.1038/Labinvest.2008.36 |
0.674 |
|
| 2008 |
Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, Appukuttan B, Gibbs D, Yang Z, Karikó K, Ambati BK, ... Wilgus TA, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 452: 591-7. PMID 18368052 DOI: 10.1038/Nature06765 |
0.311 |
|
| 2008 |
Wilgus T, Bergdall V, DiPietro L, Oberyszyn T. 167
The Effects of Hydrogen Peroxide on Fetal Wound Repair Wound Repair and Regeneration. 13: A28-A48. DOI: 10.1111/J.1067-1927.2005.130216Bs.X |
0.762 |
|
| 2008 |
Wilgus T, Oberyszyn T, Bergdall V, Ferreira A, DiPietro L. 058
Modulation of Scar Formation by Vascular Endothelial Growth Factor Wound Repair and Regeneration. 13: A4-A27. DOI: 10.1111/J.1067-1927.2005.130215Bf.X |
0.718 |
|
| 2007 |
Wilgus TA. Regenerative healing in fetal skin: a review of the literature. Ostomy/Wound Management. 53: 16-31; quiz 32-3. PMID 17586870 |
0.471 |
|
| 2006 |
Tober KL, Wilgus TA, Kusewitt DF, Thomas-Ahner JM, Maruyama T, Oberyszyn TM. Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development. The Journal of Investigative Dermatology. 126: 205-11. PMID 16417238 DOI: 10.1038/Sj.Jid.5700014 |
0.742 |
|
| 2005 |
Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. The American Journal of Pathology. 167: 1257-66. PMID 16251410 DOI: 10.1016/S0002-9440(10)61213-8 |
0.455 |
|
| 2005 |
Wilgus TA, Bergdall VK, Dipietro LA, Oberyszyn TM. Hydrogen peroxide disrupts scarless fetal wound repair. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 13: 513-9. PMID 16176460 DOI: 10.1111/J.1067-1927.2005.00072.X |
0.75 |
|
| 2004 |
Wilgus TA, Bergdall VK, Tober KL, Hill KJ, Mitra S, Flavahan NA, Oberyszyn TM. The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. The American Journal of Pathology. 165: 753-61. PMID 15331400 DOI: 10.1016/S0002-9440(10)63338-X |
0.756 |
|
| 2004 |
Wilgus TA, Breza TS, Tober KL, Oberyszyn TM. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors. The Journal of Investigative Dermatology. 122: 1488-94. PMID 15175041 DOI: 10.1111/J.0022-202X.2004.22606.X |
0.729 |
|
| 2003 |
Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Molecular Carcinogenesis. 38: 49-58. PMID 14502644 DOI: 10.1002/Mc.10141 |
0.762 |
|
| 2003 |
Wilgus TA, Koki AT, Zweifel BS, Rubal PA, Oberyszyn TM. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer. Molecular Carcinogenesis. 38: 33-9. PMID 12949841 DOI: 10.1002/Mc.10142 |
0.709 |
|
| 2003 |
Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 11: 25-34. PMID 12581424 DOI: 10.1046/J.1524-475X.2003.11106.X |
0.753 |
|
| 2002 |
Wilgus TA, Parrett ML, Ross MS, Tober KL, Robertson FM, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Advances in Experimental Medicine and Biology. 507: 85-92. PMID 12664569 DOI: 10.1007/978-1-4615-0193-0_14 |
0.76 |
|
| 2001 |
Oberyszyn TM, Robertson FM, Tober KL, Ross MS, Parrett ML, Wilgus TA, Iyer S, Woo J, Buelow R. Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide. Photochemistry and Photobiology. 73: 184-90. PMID 11272733 DOI: 10.1562/0031-8655(2001)073<0184:Ioculi>2.0.Co;2 |
0.655 |
|
| 2000 |
Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins & Other Lipid Mediators. 62: 367-84. PMID 11060900 DOI: 10.1016/S0090-6980(00)00089-7 |
0.742 |
|
| 1999 |
Wilgus TA, Robertson FM, Parrett ML, Ross MS, Tober KL, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 (COX-2) inhibitor Prostaglandins & Other Lipid Mediators. 59: 219. DOI: 10.1016/S0090-6980(99)90454-9 |
0.647 |
|
| Show low-probability matches. |